Cardiotoxicity of methamphetamine under stress conditions: Comparison of single dose and long-term use

Molecular Medicine Reports

Volumn 7, Issue 6, 2013, Pages 1786-1790

  Masafumi, Tomita ^a   Okuyama, Toshiko ^a   Katsuyama, Hironobu ^a   Watanabe, Yoko ^a   Shinone, Kotaro ^b   Nata, Masayuki ^b   Ishikawa, Takaki ^c  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiotoxicity; Methamphetamine; Mice; RNA expression; Stress

Indexed keywords

CATALASE; CHAPERONIN 60; CORTICOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; METHAMPHETAMINE; PEROXIREDOXIN 1; PHOSPHOGLYCERATE KINASE; PROSTACYCLIN; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; FOOTSHOCK; HEART; HEART MUSCLE INJURY; IMMOBILIZATION STRESS; LONG TERM CARE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TEMPERATURE STRESS; UPREGULATION; WATER IMMERSION;

ADRENERGIC AGENTS; ANIMALS; CORTICOSTERONE; HEAT-SHOCK PROTEINS; INTERLEUKIN-6; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MYOCARDIUM; RESTRAINT, PHYSICAL; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; TEMPERATURE; TIME FACTORS;

EID: 84877246030     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1408     Document Type: Article

References (35)

1. Brecht ML, von Mayrhauser C and Anglin MD: Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs 32: 211-220, 2000.
2. Comer SD, Hart CL, Ward AS, Haney M, Foltin RW and Fischman MW: Effects of repeated oral methamphetamine administration in humans. Psychopharmacology (Berl) 155: 397-404, 2001.
3. Wada K: The history and current state of drug abuse in Japan. Ann NY Acad Sci 1216: 62-72, 2011.
4. Saito T, Takeichi S, Nakajima Y, Yukawa N and Osawa M: Fatal methamphetamine poisoning in police custody. J Clin Forensic Med 3: 183-185, 1996.
5. Inoue H, Ikeda N, Kudo K, Ishida T, Terada M and Matoba R: Methamphetamine-related sudden death with a concentration which was of a 'toxic level'. Leg Med (Tokyo) 8: 150-155, 2006.
6. Wijetunga M, Seto T, Lindsay J and Schatz I: Crystal methamphetamine- associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol 41: 981-986, 2003.
7. Tsigos C and Chrousos GP: Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53: 865-871, 2002.
8. Miller GE, Chen E and Zhou ES: If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull 133: 25-45, 2007.
9. Kishi T: Heart failure as an autonomic nervous system dysfunction. J Cardiology 59: 117-122, 2012.
10. Pickering TG: Does psychological stress contribute to the development of hypertension and coronary heart disease? Eur J Clin Pharmacol 39 (Suppl 1): S1-S7, 1990.
11. Tidey JW and Miczek KA: Acquisition of cocaine self-administration after social stress: role of accumbens dopamine. Psychopharmacology (Berl) 130: 203-212, 1997.
12. Piazza PV and Le Moal M: The role of stress in drug self-administration. Trends Pharmacol Sci 19: 67-74, 1998.
13. Perkins KA and Grobe JE: Increased desire to smoke during acute stress. Br J Addict 87: 1037-1040, 1992.
14. Sinha R: How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 158: 343-359, 2001.
15. Sinha R, Catapano D and O'Malley S: Stress-induced craving and stress response in cocaine dependent individuals. Psycho-pharmacology (Berl) 142: 343-351, 1999.
16. Zhao LY, Shi J, Zhang XL and Lu L: Psychosocial stress enhances non-drug-related positive memory retrieval in male abstinent heroin addicts. Neurosci Lett 485: 16-20, 2010.
17. Söderpalm AH, Nikolayev L and de Wit H: Effects of stress on responses to methamphetamine in humans. Psychopharmacology (Berl) 170: 188-199, 2003.
18. Stratton SJ, Rogers C, Brickett K and Gruzinski G: Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 19: 187-191, 2001.
19. Uemura K, Ueyama T, Shintani-Ishida K, Unuma K and Yoshida K: An autopsy report on four sudden cardiac death cases by immobilization. Int Med J 15: 301-305, 2008.
20. Tomita M, Katsuyama H, Watanabe Y, et al: Water-restraint stress enhances methamphetamine-induced cardiotoxicity. Chem Biol Interact 190: 54-61, 2011.
21. Ikeda U, Ohkawa F, Seino Y, et al: Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 24: 579-84, 1992.
22. Jirik FR, Podor TJ, Hirano T, et al: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 142: 144-147, 1989.
23. Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J and Kishimoto T: Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91: 1520-1524, 1995.
24. Kang YJ: The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 222: 263-273, 1999.
25. Nath R, Kumar D, Li T and Singal PK: Metallothioneins, oxidative stress and the cardiovascular system. Toxicology 155: 17-26, 2000.
26. Canton M, Menazza S, Sheeran FL, Polverino de Laureto P, Di Lisa F and Pepe SP: Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol 57: 300-309, 2011.
27. Jung F, Palmer LA, Zhou N and Johns RA: Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 86: 319-325, 2000.
28. Rus A, del Moral ML, Molina F and Peinado MA: Does inducible NOS have a protective role against hypoxia/reoxygenation injury in rat heart ? Cardiovasc Pathol 20: e17-e25, 2011.
29. Miguel-Carrasco JL, Zambrano S, Blanca AJ, et al: Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB. J Inflamm (Lond) 7: 21, 2010.
30. Katragadda S and Arora RR: Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects. Am J Ther 17: e11-e23, 2010.
31. Chan EC, Dusting GJ, Guo N, et al: Prostacyclin receptor suppresses cardiac fibrosis: role of CREB phosphorylation. J Mol Cell Cardiol 49: 176-185, 2010.
32. Maulik N, Engelman RM, Rousou JA, Flack JE III, Deaton D and Das DK: Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 100 (19 Suppl): II369-II375, 1999.
33. Wu S, Storey JM and Storey KB: Phosphoglycerate kinase 1 expression responds to freezing, anoxia, and dehydration stresses in the freeze tolerant wood frog, Rana sylvatica. J Exp Zool A Ecol Genet Physiol 311: 57-67, 2009.
34. Jiang XC, Tall AR, Qin S, et al: Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem 277: 31850-31856, 2002.
35. Cavusoglu E, Marmur JD, Chhabraa S, Choprab V, Eng C and Jiangc XC: Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography. Atherosclerosis 207: 261-265, 2009.